Skip to content
WorkingMomRx
Menu

Evidence review

GLP-1 Shipment Arrived Warm? Storage and Power-Outage Steps

What to do when a GLP-1 shipment arrives warm or your refrigerator loses power, with product-specific limits and a pharmacy contact checklist.

By Dana Whitfield, Managing Editora working mom, not a treating clinicianevery figure cited to its source
On this page

The short answer

Do not use an injectable GLP-1 shipment that arrives warm or with insufficient refrigeration. FDA specifically advises against using such shipments because storage problems can affect drug quality. Contact the dispensing pharmacy promptly for instructions and a replacement assessment.1

A home power outage is a different situation: you may know when refrigeration stopped and which product you have. Follow that product's instructions and ask the pharmacist to assess any uncertain exposure. Do not use a branded product's room-temperature allowance to justify an unknown warm shipment or a compounded vial.

First, identify exactly what is in the package

The active ingredient alone is not enough. Record the brand, device or vial type, strength, expiration date, lot number and whether a multidose container has been opened. Keep the pharmacy's storage instructions. Different presentations under the same brand can have different storage limits.

For example, these are limited reference examples, not a complete storage chart:

Exact presentationLabel exampleImportant limit
U.S. Wegovy single-dose pen, before cap removalUp to 28 days at 46°F–86°F, protected in the original cartonDiscard if frozen or exposed above 86°F; this row does not cover tablets or other devices.2
U.S. Zepbound single-dose pen or single-dose vialUp to a total of 21 days at no more than 86°FDo not freeze; other Zepbound presentations have different instructions.3
Compounded injectionUse its pharmacy-specific instructions and obtain an assessment of any excursionBranded-product allowances do not establish stability of a compounded preparation.

Check the leaflet supplied with your own medicine. Labels can change as new presentations become available. If the package does not match a row exactly, do not try to adapt the number yourself.

If the delivery is warm

Photograph the shipping box, insulation, cold packs and medicine label without posting your personal information publicly. Save the tracking history and note delivery time and when you opened the parcel. If there is a temperature indicator, photograph its reading. Do not open a sterile container to investigate it.

Contact the dispensing pharmacy and the clinic that arranged delivery. Ask who is making the medication-quality decision and who handles a replacement. A customer-service statement that “the ice always melts” does not establish the temperature history of your particular shipment.

Useful questions to ask are:

  • Should this product remain unused, and how should I hold it while awaiting instructions?
  • What information do you need to assess the shipping problem?
  • Will you replace it, and what is the expected timeline?
  • Is there a charge, and where is the applicable replacement policy?
  • Should I retain the packaging for a claim or return?
  • Who should advise me if the replacement will not arrive before my next prescribed dose?

Do not send the medicine back or discard evidence before receiving instructions, unless a safety instruction requires disposal. Keep it clearly separate from medication that has been cleared for use so another household member cannot mistake the packages.

If your refrigerator loses power

Write down when the outage began and the last known refrigerator temperature, if available. Record subsequent temperatures from an actual thermometer rather than estimating from how the carton feels. Protect the product according to its label while you contact the pharmacist; avoid placing it directly against frozen packs or a cooling element.

Give the pharmacist the product details and what you know about the time and temperature. If there were previous periods outside refrigeration, report those too. Returning a product to a refrigerator does not provide evidence that earlier heat or freezing damage has been reversed. Ask for a clear use-or-discard decision for the actual circumstances.

For planning, decide where medicine could be safely stored during a longer outage and who can receive a delayed delivery if you are at work. Keep the pharmacy contact number somewhere accessible without opening the patient portal. Those small preparations are more dependable than trying to reconstruct a delivery on a busy evening.

Compounded multidose vials need an additional check

FDA's current consumer guidance recommends discarding compounded multidose sterile medication vials within 28 days after first use, even if medication remains or the compounder's instructions allow longer. It also calls for a new sterile needle and syringe for each dose.1 Ask the pharmacist about any conflict between that guidance and your dispensing instructions before use.

An unopened beyond-use date, an opened-vial limit and a temperature excursion are different questions. Write each date down separately. A long printed date does not settle whether a vial that arrived warm is usable.

Plan for a delayed replacement

If the supply is unusable or a replacement is delayed, tell your prescriber when the next dose is due. Ask for instructions appropriate to your product and interruption; this guide does not recommend making up doses or changing intervals. Our travel guide covers planning away from home, while shipping-speed comparisons address delivery expectations. A fast shipment is useful only when the medication arrives in acceptable condition.

Where this leaves you

References

  1. U.S. Food and Drug Administration (2026). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  2. Novo Nordisk (2026). Wegovy U.S. prescribing information. Novo Nordisk. https://www.novo-pi.com/wegovy.pdf
  3. Eli Lilly (2026). Zepbound U.S. prescribing information. Eli Lilly. https://pi.lilly.com/us/zepbound-uspi.pdf

Read this as information, not instructions. WorkingMomRx is educational and never a diagnosis, a treatment plan, or a reason to start or stop a medication. A GLP-1 is a clinical decision — run it past a licensed clinician who knows your history before you act on anything here.